» Articles » PMID: 35390777

Engineering Organ-on-a-chip Systems to Model Viral Infections

Overview
Journal Biofabrication
Date 2022 Apr 7
PMID 35390777
Authors
Affiliations
Soon will be listed here.
Abstract

Infectious diseases remain a public healthcare concern worldwide. Amidst the pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, increasing resources have been diverted to investigate therapeutics targeting the COVID-19 spike glycoprotein and to develop various classes of vaccines. Most of the current investigations employ two-dimensional (2D) cell culture and animal models. However, 2D culture negates the multicellular interactions and three-dimensional (3D) microenvironment, and animal models cannot mimic human physiology because of interspecies differences. On the other hand, organ-on-a-chip (OoC) devices introduce a game-changer to model viral infections in human tissues, facilitating high-throughput screening of antiviral therapeutics. In this context, this review provides an overview of theOoC-based modeling of viral infection, highlighting the strengths and challenges for the future.

Citing Articles

Flavonoids attenuate inflammation of HGF and HBMSC while modulating the osteogenic differentiation based on microfluidic chip.

Du S, Wang Z, Zhu H, Tang Z, Li Q J Transl Med. 2024; 22(1):992.

PMID: 39488714 PMC: 11531701. DOI: 10.1186/s12967-024-05808-1.


Recreating the biological steps of viral infection on a cell-free bioelectronic platform to profile viral variants of concern.

Chao Z, Selivanovitch E, Kallitsis K, Lu Z, Pachaury A, Owens R Nat Commun. 2024; 15(1):5606.

PMID: 38961055 PMC: 11222515. DOI: 10.1038/s41467-024-49415-6.


Vasculature-on-a-chip technologies as platforms for advanced studies of bacterial infections.

Gaudreau L, Stewart E Biomicrofluidics. 2024; 18(2):021503.

PMID: 38560344 PMC: 10977040. DOI: 10.1063/5.0179281.


The use of single-cell RNA-seq to study heterogeneity at varying levels of virus-host interactions.

Swaminath S, Russell A PLoS Pathog. 2024; 20(1):e1011898.

PMID: 38236826 PMC: 10796064. DOI: 10.1371/journal.ppat.1011898.


Challenges in development of vaccines directed toward antimicrobial resistant bacterial species.

Brazzoli M, Piccioli D, Marchetti F Hum Vaccin Immunother. 2023; 19(2):2228669.

PMID: 37449650 PMC: 10351463. DOI: 10.1080/21645515.2023.2228669.


References
1.
Bag P, Chattopadhyay D, Mukherjee H, Ojha D, Mandal N, Sarkar M . Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands. Virol J. 2012; 9:98. PMC: 3430555. DOI: 10.1186/1743-422X-9-98. View

2.
Jennings V, Scott G, Rose A, Scott K, Migneco G, Keller B . Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition. Mol Ther. 2019; 27(6):1139-1152. PMC: 6554638. DOI: 10.1016/j.ymthe.2019.04.008. View

3.
Ashammakhi N, Ali Darabi M, Celebi-Saltik B, Tutar R, Hartel M, Lee J . Microphysiological Systems: Next Generation Systems for Assessing Toxicity and Therapeutic Effects of Nanomaterials. Small Methods. 2020; 4(1). PMC: 7546538. DOI: 10.1002/smtd.201900589. View

4.
Bein A, Shin W, Jalili-Firoozinezhad S, Park M, Sontheimer-Phelps A, Tovaglieri A . Microfluidic Organ-on-a-Chip Models of Human Intestine. Cell Mol Gastroenterol Hepatol. 2018; 5(4):659-668. PMC: 5924739. DOI: 10.1016/j.jcmgh.2017.12.010. View

5.
Huang S, Lin Y, Wu C, Wu C . Assessment of the inhibition of Dengue virus infection by carrageenan via real-time monitoring of cellular oxygen consumption rates within a microfluidic device. Biomicrofluidics. 2014; 8(2):024110. PMC: 4222297. DOI: 10.1063/1.4870772. View